Neurobiology of addiction: a neurocircuitry analysis

The Lancet Psychiatry

Volumn 3, Issue 8, 2016, Pages 760-773

  Koob, George F ^a   Volkow, Nora D ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DOPAMINE; DYNORPHIN; GLUTAMIC ACID; TRANSCRIPTION FACTOR;

ADDICTION; ALCOHOLISM; AMYGDALA; ANTICIPATION; BASAL GANGLION; CONCEPTUAL FRAMEWORK; DRUG DEPENDENCE; DRUG INTOXICATION; EXECUTIVE FUNCTION; HUMAN; INSULA; MOLECULAR GENETICS; NEUROBIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; REWARD; SALIENCE NETWORK; BRAIN; NERVE TRACT; PATHOPHYSIOLOGY;

BRAIN; HUMANS; NEURAL PATHWAYS; NEUROBIOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 84995616656     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)00104-8     Document Type: Review

References (186)

1. 1 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edn., 2013, American Psychiatric Publishing, Washington DC.
2. 2 Koob, GF, Le Moal, M, Addiction and the brain antireward system. Annu Rev Psychol 59 (2008), 29–53.
3. 3 McLellan, AT, Lewis, DC, O'Brien, CP, Kleber, HD, Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284 (2000), 1689–1695.
4. 4 Koob, GF, Le Moal, M, Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997), 52–58.
5. 5 Goldstein, RZ, Volkow, ND, Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159 (2002), 1642–1652.
6. 6 Baumeister, RF, Heatherton, TF, Tice, DM, Losing control: how and why people fail at self-regulation, 1994, Academic Press, San Diego.
7. 7 Moeller, FG, Barratt, ES, Dougherty, DM, Schmitz, JM, Swann, AC, Psychiatric aspects of impulsivity. Am J Psychiatry 158 (2001), 1783–1793.
8. 8 Berlin, GS, Hollander, E, Compulsivity, impulsivity, and the DSM-5 process. CNS Spectr 19 (2014), 62–68.
9. 9 Koob, GF, Volkow, ND, Neurocircuitry of addiction. Neuropsychopharmacology 35 (2010), 217–238.
10. 10 Shippenberg, TS, Koob, GF, Recent advances in animal models of drug addiction and alcoholism. Davis, KL, Charney, D, Coyle, JT, Nemeroff, C, (eds.) Neuropsychopharmacology: the fifth generation of progress, 2002, Lippincott Williams and Wilkins, Philadelphia, 1381–1397.
11. 11 Geyer, MA, Markou, A, Animal models of psychiatric disorders. Bloom, FE, Kupfer, DJ, (eds.) Psychopharmacology: the fourth generation of progress, 1995, Raven Press, New York, 787–798.
12. 12 Koob, GF, Le Moal, M, Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001), 97–129.
13. 13 Koob, GF, Mason, BJ, Existing and future drugs for the treatment of the dark side of addiction. Annu Rev Pharmacol Toxicol 56 (2016), 299–322.
14. 14 Goldstein, RZ, Volkow, ND, Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12 (2011), 652–669.
15. 15 Everitt, BJ, Belin, D, Economidou, D, Pelloux, Y, Dalley, JW, Robbins, TW, Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363 (2008), 3125–3135.
16. 16 Mitchell, JM, O'Neil, JP, Janabi, M, Marks, SM, Jagust, WJ, Fields, HL, Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Sci Transl Med, 4, 2012, 116ra6.
17. 17 Cunningham, KA, Anastasio, NC, Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology 76 (2014), 460–478.
18. A receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area. Front Pharmacol, 5, 2014, 256.
19. 19 Dani, JA, Heinemann, S, Molecular and cellular aspects of nicotine abuse. Neuron 16 (1996), 905–908.
20. 20 Koob, GF, Buck, CL, Cohen, A, et al. Addiction as a stress surfeit disorder. Neuropharmacology 76 (2014), 370–382.
21. 21 Carlezon, WA Jr, Nestler, EJ, Neve, RL, Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol 14 (2000), 47–67.
22. 22 Delfs, JM, Zhu, Y, Druhan, JP, Aston-Jones, G, Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403 (2000), 430–434.
23. 23 Boutrel, B, de Lecea, L, Addiction and arousal: the hypocretin connection. Physiol Behav 93 (2008), 947–951.
24. 24 Maldonado, R, Girdlestone, D, Roques, BP, RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats. Neurosci Lett 156 (1993), 135–140.
25. 25 Martinez, D, Narendran, R, Foltin, RW, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164 (2007), 622–629.
26. 26 Al-Hasani, R, Bruchas, MR, Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115 (2011), 1363–1381.
27. 27 Heilig, M, Thorsell, A, Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev Neurosci 13 (2002), 85–94.
28. 28 Economidou, D, Cippitelli, A, Stopponi, S, et al. Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat. Alcohol Clin Exp Res 35 (2011), 747–755.
29. 29 Sidhpura, N, Parsons, LH, Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology 61 (2011), 1070–1087.
30. 30 Sarnyai, Z, Kovács, GL, Role of oxytocin in the neuroadaptation to drugs of abuse. Psychoneuroendocrinology 19 (1994), 85–117.
31. 18F]fallypride study in cocaine dependent participants. Neuropsychopharmacology 38 (2013), 1780–1788.
32. 32 Kalivas, PW, The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10 (2009), 561–572.
33. 33 Shalev, U, Grimm, JW, Shaham, Y, Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54 (2002), 1–42.
34. 34 Wise, RA, Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction. Trends Neurosci 32 (2009), 517–524.
35. 35 Volkow, ND, Wang, GJ, Telang, F, et al. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 27 (2007), 12700–12706.
36. 36 Volkow, ND, Fowler, JS, Wang, GJ, The addicted human brain: insights from imaging studies. J Clin Invest 111 (2003), 1444–1451.
37. 1 receptor knock-out mice. J Neurosci 27 (2007), 13140–13150.
38. 38 Zweifel, LS, Parker, JG, Lobb, CJ, et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci USA 106 (2009), 7281–7288.
39. 39 Norman, AB, Tabet, MR, Norman, MK, Fey, BK, Tsibulsky, VL, Millard, RW, The affinity of D2-like dopamine receptor antagonists determines the time to maximal effect on cocaine self-administration. J Pharmacol Exp Ther 338 (2011), 724–728.
40. 40 Caine, SB, Negus, SS, Mello, NK, et al. Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22 (2002), 2977–2988.
41. 41 Durieux, PF, Bearzatto, B, Guiducci, S, et al. D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat Neurosci 12 (2009), 393–395.
42. 42 Covey, DP, Roitman, MF, Garris, PA, Illicit dopamine transients: reconciling actions of abused drugs. Trends Neurosci 37 (2014), 200–210.
43. 43 Lüscher, C, Malenka, RC, Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69 (2011), 650–663.
44. 44 Tolu, S, Eddine, R, Marti, F, et al. Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Mol Psychiatry 18 (2013), 382–393.
45. 45 Belin, D, Jonkman, S, Dickinson, A, Robbins, TW, Everitt, BJ, Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res 199 (2009), 89–102.
46. 46 Wolf, ME, Ferrario, CR, AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine. Neurosci Biobehav Rev 35 (2010), 185–211.
47. 47 Grieder, TE, Herman, MA, Contet, C, et al. VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation. Nat Neurosci 17 (2014), 1751–1758.
48. 48 Fowler, CD, Lu, Q, Johnson, PM, Marks, MJ, Kenny, PJ, Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471 (2011), 597–601.
49. 49 Heilig, M, The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004), 213–224.
50. 50 George, O, Sanders, C, Freiling, J, et al. Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proc Natl Acad Sci USA 109 (2012), 18156–18161.
51. 51 Vorel, SR, Liu, X, Hayes, RJ, Spector, JA, Gardner, EL, Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292 (2001), 1175–1178.
52. 52 Everitt, BJ, Wolf, ME, Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22 (2002), 3312–3320.
53. 53 Shaham, Y, Shalev, U, Lu, L, De Wit, H, Stewart, J, The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168 (2003), 3–20.
54. 54 Naqvi, NH, Bechara, A, The hidden island of addiction: the insula. Trends Neurosci 32 (2009), 56–67.
55. 55 Robbins, TW, Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs. Nature 264 (1976), 57–59.
56. 56 Berridge, MJ, Calcium signalling remodelling and disease. Biochem Soc Trans 40 (2012), 297–309.
57. 57 Schultz, W, Dayan, P, Montague, PR, A neural substrate of prediction and reward. Science 275 (1997), 1593–1599.
58. 58 Ungless, MA, Whistler, JL, Malenka, RC, Bonci, A, Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001), 583–587.
59. 59 Belin, D, Everitt, BJ, Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57 (2008), 432–441.
60. 60 Roitman, MF, Stuber, GD, Phillips, PE, Wightman, RM, Carelli, RM, Dopamine operates as a subsecond modulator of food seeking. J Neurosci 24 (2004), 1265–1271.
61. 61 Volkow, ND, Tomasi, D, Wang, GJ, et al. Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers. Mol Psychiatry 19 (2014), 1037–1043.
62. 62 Grace, AA, The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95:suppl 2 (2000), S119–S128.
63. 63 Volkow, ND, Morales, M, The brain on drugs: from reward to addiction. Cell 162 (2015), 712–725.
64. 2 autoreceptors. Nat Neurosci 14 (2011), 1033–1038.
65. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22 (2002), 9595–9603.
66. 66 Koob, GF, Le Moal, M, Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nat Neurosci 8 (2005), 1442–1444.
67. 67 Garavan, H, Pankiewicz, J, Bloom, A, et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157 (2000), 1789–1798.
68. 68 Koob, GF, Bloom, FE, Cellular and molecular mechanisms of drug dependence. Science 242 (1988), 715–723.
69. 69 Weiss, F, Markou, A, Lorang, MT, Koob, GF, Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593 (1992), 314–318.
70. 70 Volkow, ND, Wang, GJ, Fowler, JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386 (1997), 830–833.
71. 71 Stinus, L, Le Moal, M, Koob, GF, Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37 (1990), 767–773.
72. 72 Minkowski, CP, Epstein, D, Frost, JJ, Gorelick, DA, Differential response to IV carfentanil in chronic cocaine users and healthy controls. Addict Biol 17 (2012), 149–155.
73. 73 Davidson, M, Shanley, B, Wilce, P, Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study. Brain Res 674 (1995), 91–96.
74. 74 Dahchour, A, De Witte, P, Bolo, N, et al. Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82 (1998), 107–114.
75. 75 Piazza, PV, Le Moal, ML, Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36 (1996), 359–378.
76. 76 Walker, BM, Koob, GF, Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence. Neuropsychopharmacology 33 (2008), 643–652.
77. 77 Schlosburg, JE, Whitfield, TW Jr, Park, PE, et al. Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake. J Neurosci 33 (2013), 19384–19392.
78. 78 Whitfield, TW Jr, Schlosburg, JE, Wee, S, et al. κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake. J Neurosci 35 (2015), 4296–4305.
79. 79 Hikosaka, O, The habenula: from stress evasion to value-based decision-making. Nat Rev Neurosci 11 (2010), 503–513.
80. 80 Matsumoto, M, Hikosaka, O, Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 447 (2007), 1111–1115.
81. 81 Kimura, M, Satoh, T, Matsumoto, N, What does the habenula tell dopamine neurons?. Nat Neurosci 10 (2007), 677–678.
82. 82 Salas, R, Sturm, R, Boulter, J, De Biasi, M, Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 29 (2009), 3014–3018.
83. 83 Gillan, CM, Morein-Zamir, S, Urcelay, GP, et al. Enhanced avoidance habits in obsessive-compulsive disorder. Biol Psychiatry 75 (2014), 631–638.
84. 84 Reisiger, AR, Kaufling, J, Manzoni, O, Cador, M, Georges, F, Caillé, S, Nicotine self-administration induces CB1-dependent LTP in the bed nucleus of the stria terminalis. J Neurosci 34 (2014), 4285–4292.
85. 85 Gunduz-Cinar, O, MacPherson, KP, Cinar, R, et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry 18 (2013), 813–823.
86. 86 Hirvonen, J, Goodwin, RS, Li, CT, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17 (2012), 642–649.
87. 87 Ceccarini, J, Hompes, T, Verhaeghen, A, et al. Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence. J Neurosci 34 (2014), 2822–2831.
88. 88 Leventhal, AM, Kahler, CW, Ray, LA, et al. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. Am J Addict 17 (2008), 218–223.
89. 89 Tiffany, ST, Carter, BL, Singleton, EG, Challenges in the manipulation, assessment and interpretation of craving relevant variables. Addiction 95:suppl 2 (2000), S177–S187.
90. 90 Geisler, S, Wise, RA, Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci 19 (2008), 227–244.
91. 91 Koob, GF, Arends, MA, Le Moal, M, Drugs, addiction, and the brain, 2014, Academic Press, San Diego.
92. 92 Jentsch, JD, Taylor, JR, Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146 (1999), 373–390.
93. 93 Chudasama, Y, Robbins, TW, Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 73 (2006), 19–38.
94. 94 McFarland, K, Kalivas, PW, The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21 (2001), 8655–8663.
95. 95 Vanderschuren, LJMJ, Di Ciano, P, Everitt, BJ, Involvement of the dorsal striatum in cue-controlled cocaine seeking. J Neurosci 25 (2005), 8665–8670.
96. 96 Shaham, Y, Highfield, D, Delfs, J, Leung, S, Stewart, J, Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci 12 (2000), 292–302.
97. 97 Shaham, Y, Erb, S, Leung, S, Buczek, Y, Stewart, J, CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berl) 137 (1998), 184–190.
98. 98 Merlo Pich, E, Lorang, M, Yeganeh, M, et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15 (1995), 5439–5447.
99. 99 De Witte, P, Littleton, J, Parot, P, Koob, G, Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 19 (2005), 517–537.
100. 100 Valdez, GR, Roberts, AJ, Chan, K, et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26 (2002), 1494–1501.
101. 101 Kober, H, Lacadie, CM, Wexler, BE, Malison, RT, Sinha, R, Potenza, MN, Brain activity during cocaine craving and gambling urges: an fMRI study. Neuropsychopharmacology 41 (2016), 628–637.
102. 102 Lee, JH, Lim, Y, Wiederhold, BK, Graham, SJ, A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedback 30 (2005), 195–204.
103. 103 Risinger, RC, Salmeron, BJ, Ross, TJ, et al. Neural correlates of high and craving during cocaine self-administration using BOLD fMRI. Neuroimage 26 (2005), 1097–1108.
104. 104 Volkow, ND, Wang, GJ, Ma, Y, et al. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci 25 (2005), 3932–3939.
105. 105 Jasinska, AJ, Stein, EA, Kaiser, J, Naumer, MJ, Yalachkov, Y, Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies. Neurosci Biobehav Rev 38 (2014), 1–16.
106. 106 Volkow, ND, Wang, GJ, Telang, F, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26 (2006), 6583–6588.
107. 107 Milella, MS, Fotros, A, Gravel, P, et al. Cocaine cue-induced dopamine release in the human prefrontal cortex. J Psychiatry Neurosci, 41, 2016, 150207.
108. 108 Volkow, ND, Wang, GJ, Fowler, JS, et al. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry 156 (1999), 19–26.
109. 109 Volkow, ND, Wang, GJ, Fowler, JS, Tomasi, D, Telang, F, Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 108 (2011), 15037–15042.
110. 110 Rando, K, Hong, KI, Bhagwagar, Z, et al. Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study. Am J Psychiatry 168 (2011), 183–192.
111. 111 Bonson, KR, Grant, SJ, Contoreggi, CS, et al. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26 (2002), 376–386.
112. 112 Pelchat, ML, Johnson, A, Chan, R, Valdez, J, Ragland, JD, Images of desire: food-craving activation during fMRI. Neuroimage 23 (2004), 1486–1493.
113. 113 Wang, Z, Faith, M, Patterson, F, et al. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci 27 (2007), 14035–14040.
114. 114 Naqvi, NH, Rudrauf, D, Damasio, H, Bechara, A, Damage to the insula disrupts addiction to cigarette smoking. Science 315 (2007), 531–534.
115. 115 Clark, L, Bechara, A, Damasio, H, Aitken, MR, Sahakian, BJ, Robbins, TW, Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain 131 (2008), 1311–1322.
116. 116 Verdejo-Garcia, A, Contreras-Rodríguez, O, Fonseca, F, et al. Functional alteration in frontolimbic systems relevant to moral judgment in cocaine-dependent subjects. Addict Biol 19 (2014), 272–281.
117. 117 Sánchez, MM, Young, LJ, Plotsky, PM, Insel, TR, Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408 (1999), 365–377.
118. 118 Goudriaan, AE, de Ruiter, MB, van den Brink, W, Oosterlaan, J, Veltman, DJ, Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addict Biol 15 (2010), 491–503.
119. 119 Janes, AC, Pizzagalli, DA, Richardt, S, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 67 (2010), 722–729.
120. 120 Volkow, ND, Fowler, JS, Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 10 (2000), 318–325.
121. 121 Volkow, ND, Wang, GJ, Fowler, JS, Telang, F, Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 363 (2008), 3191–3200.
122. 122 Volkow, ND, Fowler, JS, Wang, GJ, Baler, R, Telang, F, Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56:suppl 1 (2009), 3–8.
123. 123 Volkow, ND, Fowler, JS, Wang, GJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14 (1993), 169–177.
124. 124 Volkow, ND, Chang, L, Wang, GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158 (2001), 2015–2021.
125. 3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 29 (2009), 14734–14740.
126. 126 Wang, GJ, Smith, L, Volkow, ND, et al. Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry 17 (2012), 918–925.
127. 127 Niendam, TA, Laird, AR, Ray, KL, Dean, YM, Glahn, DC, Carter, CS, Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci 12 (2012), 241–268.
128. 128 Contreras-Rodríguez, O, Albein-Urios, N, Perales, JC, et al. Cocaine-specific neuroplasticity in the ventral striatum network is linked to delay discounting and drug relapse. Addiction 110 (2015), 1953–1962.
129. 129 Bryant, RA, Felmingham, KL, Kemp, AH, et al. Neural networks of information processing in posttraumatic stress disorder: a functional magnetic resonance imaging study. Biol Psychiatry 58 (2005), 111–118.
130. 130 Damasio, AR, The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 351 (1996), 1413–1420.
131. 131 Bechara, A, Damasio, H, Damasio, AR, Lee, GP, Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 19 (1999), 5473–5481.
132. 132 Johnstone, T, van Reekum, CM, Urry, HL, Kalin, NH, Davidson, RJ, Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J Neurosci 27 (2007), 8877–8884.
133. 133 Pitman, RK, Rasmusson, AM, Koenen, KC, et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 13 (2012), 769–787.
134. 134 Mcdonald, AJ, Mascagni, F, Guo, L, Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience 71 (1996), 55–75.
135. 135 Volkow, ND, Fowler, JS, Wang, GJ, et al. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage 49 (2010), 2536–2543.
136. 136 Self, DW, Genova, LM, Hope, BT, Barnhart, WJ, Spencer, JJ, Nestler, EJ, Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 18 (1998), 1848–1859.
137. 137 Edwards, S, Koob, GF, Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol 5 (2010), 393–401.
138. 138 Carlezon, WA Jr, Thome, J, Olson, VG, et al. Regulation of cocaine reward by CREB. Science 282 (1998), 2272–2275.
139. 139 Nestler, EJ, Molecular mechanisms of drug addiction. Neuropharmacology 47:suppl 1 (2004), 24–32.
140. 140 Pandey, SC, Sakharkar, AJ, Tang, L, Zhang, H, Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood. Neurobiol Dis 82 (2015), 607–619.
141. 141 Nestler, EJ, Is there a common molecular pathway for addiction?. Nat Neurosci 8 (2005), 1445–1449.
142. 142 Kelz, MB, Chen, J, Carlezon, WA Jr, et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401 (1999), 272–276.
143. 143 Feng, J, Wilkinson, M, Liu, X, et al. Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens. Genome Biol, 15, 2014, R65.
144. 144 Conrad, KL, Tseng, KY, Uejima, JL, et al. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454 (2008), 118–121.
145. 145 Schmidt, HD, Kimmey, BA, Arreola, AC, Pierce, RC, Group I metabotropic glutamate receptor-mediated activation of PKC γ in the nucleus accumbens core promotes the reinstatement of cocaine seeking. Addict Biol 20 (2015), 285–296.
146. 146 Loweth, JA, Scheyer, AF, Milovanovic, M, et al. Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving. Nat Neurosci 17 (2014), 73–80.
147. 147 Costa-Mattioli, M, Sossin, WS, Klann, E, Sonenberg, N, Translational control of long-lasting synaptic plasticity and memory. Neuron 61 (2009), 10–26.
148. 148 Costa-Mattioli, M, Monteggia, LM, mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16 (2013), 1537–1543.
149. 149 Neasta, J, Barak, S, Hamida, SB, Ron, D, mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse. J Neurochem 130 (2014), 172–184.
150. 150 Shi, X, Miller, JS, Harper, LJ, Poole, RL, Gould, TJ, Unterwald, EM, Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition. Psychopharmacology (Berl) 231 (2014), 3109–3118.
151. 151 Barak, S, Liu, F, Ben Hamida, S, et al. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat Neurosci 16 (2013), 1111–1117.
152. 152 Lerman, C, Berrettini, W, Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 118B (2003), 48–54.
153. 153 Matthes, HWD, Maldonado, R, Simonin, F, et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383 (1996), 819–823.
154. 154 Ledent, C, Valverde, O, Cossu, G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999), 401–404.
155. 155 Laakso, A, Mohn, AR, Gainetdinov, RR, Caron, MG, Experimental genetic approaches to addiction. Neuron 36 (2002), 213–228.
156. 156 Uhl, GR, Grow, RW, The burden of complex genetics in brain disorders. Arch Gen Psychiatry 61 (2004), 223–229.
157. 157 Hancock, DB, Reginsson, GW, Gaddis, NC, et al. Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence. Transl Psychiatr, 5, 2015, e651.
158. 158 Olfson, E, Saccone, NL, Johnson, EO, et al. Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. Mol Psychiatry 21 (2016), 601–607.
159. 159 Nelson, EC, Agrawal, A, Heath, AC, et al. Evidence of CNIH3 involvement in opioid dependence. Mol Psychiatry 21 (2016), 608–614.
160. 160 Chen, YC, Lu, RB, Peng, GS, et al. Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele. Alcohol Clin Exp Res 23 (1999), 1853–1860.
161. 161 Kim, JI, Ganesan, S, Luo, SX, et al. Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons. Science 350 (2015), 102–106.
162. 162 Benowitz, NL, Swan, GE, Jacob, P 3rd, Lessov-Schlaggar, CN, Tyndale, RF, CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clin Pharmacol Ther 80 (2006), 457–467.
163. 163 Treutlein, J, Kissling, C, Frank, J, et al. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11 (2006), 594–602.
164. 164 Blomeyer, D, Treutlein, J, Esser, G, Schmidt, MH, Schumann, G, Laucht, M, Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry 63 (2008), 146–151.
165. 165 Dincheva, I, Drysdale, AT, Hartley, CA, et al. FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun, 6, 2015, 6395.
166. 166 Wagner, FA, Anthony, JC, From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26 (2002), 479–488.
167. 167 Spear, LP, Adolescent neurodevelopment. J Adolesc Health 52:suppl 2 (2013), S7–13.
168. 168 Giedd, JN, Blumenthal, J, Jeffries, NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2 (1999), 861–863.
169. 169 Grant, BF, Harford, TC, Muthen, BO, Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up study. J Subst Abuse, 13, 2001, 493 304.
170. 170 Volkow, ND, Altered pathways: drug abuse and age of onset. Addict Professional, 26, 2006, 29.
171. 171 Hingson, RW, Heeren, T, Winter, MR, Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment. Pediatrics 118 (2006), e755–e763.
172. 172 King, KM, Chassin, L, A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence. J Stud Alcohol Drugs 68 (2007), 256–265.
173. 173 Hanson, KL, Medina, KL, Padula, CB, Tapert, SF, Brown, SA, Impact of adolescent alcohol and drug use on neuropsychological functioning in young adulthood: 10-year outcomes. J Child Adolesc Subst Abuse 20 (2011), 135–154.
174. 174 Squeglia, LM, Spadoni, AD, Infante, MA, Myers, MG, Tapert, SF, Initiating moderate to heavy alcohol use predicts changes in neuropsychological functioning for adolescent girls and boys. Psychol Addict Behav 23 (2009), 715–722.
175. 175 Squeglia, LM, Tapert, SF, Sullivan, EV, et al. Brain development in heavy-drinking adolescents. Am J Psychiatry 172 (2015), 531–542.
176. 176 Vargas, WM, Bengston, L, Gilpin, NW, Whitcomb, BW, Richardson, HN, Alcohol binge drinking during adolescence or dependence during adulthood reduces prefrontal myelin in male rats. J Neurosci 34 (2014), 14777–14782.
177. 177 Hawkins, JD, Catalano, RF, Miller, JY, Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 112 (1992), 64–105.
178. 178 Sloboda, Z, Glantz, MD, Tarter, RE, Revisiting the concepts of risk and protective factors for understanding the etiology and development of substance use and substance use disorders: implications for prevention. Subst Use Misuse 47 (2012), 944–962.
179. 179 Smith, DE, The process of addictions and the new ASAM definition of addiction. J Psychoactive Drugs 44 (2012), 1–4.
180. 180 Koob, GF, Impulse control disorders, 2013, Cognella, San Diego.
181. 181 Volkow, ND, Wang, GJ, Telang, F, et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 42 (2008), 1537–1543.
182. 182 Yau, YH, Potenza, MN, Gambling disorder and other behavioral addictions: recognition and treatment. Harv Rev Psychiatry 23 (2015), 134–146.
183. 183 Volkow, ND, Baler, RD, NOW vs LATER brain circuits: implications for obesity and addiction. Trends Neurosci 38 (2015), 345–352.
184. 184 Lemieux, A, al'Absi, M, Stress psychobiology in the context of addiction medicine: from drugs of abuse to behavioral addictions. Prog Brain Res 223 (2016), 43–62.
185. 185 Koob, GF, Kenneth Lloyd, G, Mason, BJ, Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov 8 (2009), 500–515.
186. 186 Kwako, LE, Momenan, R, Litten, RZ, Koob, GF, Goldman, D, Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry, 2015, 10.1016/j.biopsych.2015.10.024 published online Nov 17.